Strain-Dependent Differences in Bone Development, Myeloid Hyperplasia, Morbidity and Mortality in Ptpn2-Deficient Mice

Single nucleotide polymorphisms in the gene encoding the protein tyrosine phosphatase TCPTP (encoded by PTPN2) have been linked with the development of autoimmunity. Here we have used Cre/LoxP recombination to generate Ptpn2ex2−/ex2− mice with a global deficiency in TCPTP on a C57BL/6 background and compared the phenotype of these mice to Ptpn2−/− mice (BALB/c-129SJ) generated previously by homologous recombination and backcrossed onto the BALB/c background. Ptpn2ex2−/ex2− mice exhibited growth retardation and a median survival of 32 days, as compared to 21 days for Ptpn2−/− (BALB/c) mice, but the overt signs of morbidity (hunched posture, piloerection, decreased mobility and diarrhoea) evident in Ptpn2−/− (BALB/c) mice were not detected in Ptpn2ex2−/ex2− mice. At 14 days of age, bone development was delayed in Ptpn2−/− (BALB/c) mice. This was associated with increased trabecular bone mass and decreased bone remodeling, a phenotype that was not evident in Ptpn2ex2−/ex2− mice. Ptpn2ex2−/ex2− mice had defects in erythropoiesis and B cell development as evident in Ptpn2−/− (BALB/c) mice, but not splenomegaly and did not exhibit an accumulation of myeloid cells in the spleen as seen in Ptpn2−/− (BALB/c) mice. Moreover, thymic atrophy, another feature of Ptpn2−/− (BALB/c) mice, was delayed in Ptpn2ex2−/ex2− mice and preceded by an increase in thymocyte positive selection and a concomitant increase in lymph node T cells. Backcrossing Ptpn2−/− (BALB/c) mice onto the C57BL/6 background largely recapitulated the phenotype of Ptpn2ex2−/ex2− mice. Taken together these results reaffirm TCPTP's important role in lymphocyte development and indicate that the effects on morbidity, mortality, bone development and the myeloid compartment are strain-dependent.

[1]  M. Tremblay,et al.  T cell protein tyrosine phosphatase deficiency results in spontaneous synovitis and subchondral bone resorption in mice. , 2012, Arthritis and rheumatism.

[2]  G. Karsenty,et al.  T-Cell Protein Tyrosine Phosphatase Regulates Bone Resorption and Whole-Body Insulin Sensitivity through Its Expression in Osteoblasts , 2012, Molecular and Cellular Biology.

[3]  M. Tremblay,et al.  T cell protein tyrosine phosphatase attenuates T cell signaling to maintain tolerance in mice. , 2011, The Journal of clinical investigation.

[4]  B. Neel,et al.  Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance. , 2011, Cell metabolism.

[5]  P. Elliott,et al.  Meta-Analysis of Genome-Wide Association Studies in >80 000 Subjects Identifies Multiple Loci for C-Reactive Protein Levels , 2011, Circulation.

[6]  K. Cerosaletti,et al.  An autoimmune-associated variant in PTPN2 reveals an impairment of IL-2R signaling in CD4+ T cells , 2010, Genes and Immunity.

[7]  M. Tremblay,et al.  T-Cell Protein Tyrosine Phosphatase Attenuates STAT3 and Insulin Signaling in the Liver to Regulate Gluconeogenesis , 2010, Diabetes.

[8]  J. Lötvall,et al.  B Cells: From Early Development to Regulating Allergic Diseases , 2010, Archivum Immunologiae et Therapiae Experimentalis.

[9]  S. Hardy,et al.  Increased Susceptibility to Dextran Sulfate Sodium Induced Colitis in the T Cell Protein Tyrosine Phosphatase Heterozygous Mouse , 2010, PloS one.

[10]  A. Ferrando,et al.  Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia , 2009, Nature Genetics.

[11]  J. Strouboulis,et al.  Erythropoiesis: Model systems, molecular regulators, and developmental programs , 2009, IUBMB life.

[12]  Z. Ling,et al.  Genomic-wide analysis of lymphatic metastasis-associated genes in human hepatocellular carcinoma. , 2009, World journal of gastroenterology.

[13]  Cisca Wijmenga,et al.  Shared and distinct genetic variants in type 1 diabetes and celiac disease. , 2008, The New England journal of medicine.

[14]  T. Tiganis,et al.  DNA replication stalling attenuates tyrosine kinase signaling to suppress S phase progression. , 2008, Cancer cell.

[15]  S. Chiba,et al.  Hematopoietic Stem Cell , 2020, Definitions.

[16]  R. A. Bailey,et al.  Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes , 2007, Nature Genetics.

[17]  S. Orkin,et al.  Rb Regulates Interactions between Hematopoietic Stem Cells and Their Bone Marrow Microenvironment , 2007, Cell.

[18]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[19]  M. Tremblay,et al.  TC-PTP-deficient bone marrow stromal cells fail to support normal B lymphopoiesis due to abnormal secretion of interferon-{gamma}. , 2007, Blood.

[20]  J. Kaye,et al.  Development of all CD4 T lineages requires nuclear factor TOX. , 2008, The Journal of experimental medicine.

[21]  A. Bennett,et al.  Protein tyrosine phosphatase function: the substrate perspective. , 2007, The Biochemical journal.

[22]  I. Lossos,et al.  T-Cell Protein Tyrosine Phosphatase, Distinctively Expressed in Activated-B-Cell-Like Diffuse Large B-Cell Lymphomas, Is the Nuclear Phosphatase of STAT6 , 2007, Molecular and Cellular Biology.

[23]  M. Tremblay,et al.  T-Cell Protein Tyrosine Phosphatase (Tcptp) Is a Negative Regulator of Colony-Stimulating Factor 1 Signaling and Macrophage Differentiation , 2006, Molecular and Cellular Biology.

[24]  D. Scadden,et al.  The hematopoietic stem cell in its place , 2006, Nature Immunology.

[25]  K. Moore,et al.  Stem Cells and Their Niches , 2006, Science.

[26]  M. Seibel,et al.  Perinatal testosterone surge is required for normal adult bone size but not for normal bone remodeling. , 2006, American journal of physiology. Endocrinology and metabolism.

[27]  S. Jameson,et al.  Central tolerance: learning self-control in the thymus , 2005, Nature Reviews Immunology.

[28]  G. Fantuzzi,et al.  Induction of thymocyte apoptosis by systemic administration of concanavalin A in mice: role of TNF‐α, IFN‐γ and glucocorticoids , 2005 .

[29]  M. Tremblay,et al.  Selective regulation of tumor necrosis factor–induced Erk signaling by Src family kinases and the T cell protein tyrosine phosphatase , 2005, Nature Immunology.

[30]  F. Haj,et al.  Coordinated Regulation of Insulin Signaling by the Protein Tyrosine Phosphatases PTP1B and TCPTP , 2005, Molecular and Cellular Biology.

[31]  S. Iwata,et al.  A novel mechanism for imatinib mesylate (STI571) resistance in CML cell line KT-1: role of TC-PTP in modulating signals downstream from the BCR-ABL fusion protein. , 2004, Experimental hematology.

[32]  E. Newell,et al.  T-cell protein tyrosine phosphatase deletion results in progressive systemic inflammatory disease. , 2004, Blood.

[33]  Steffen Jung,et al.  Blood monocytes consist of two principal subsets with distinct migratory properties. , 2003, Immunity.

[34]  N. Tonks,et al.  Regulation of Insulin Receptor Signaling by the Protein Tyrosine Phosphatase TCPTP , 2003, Molecular and Cellular Biology.

[35]  Tetsuya Yamamoto,et al.  The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation. , 2002, Biochemical and biophysical research communications.

[36]  J. ten Hoeve,et al.  Identification of a Nuclear Stat1 Protein Tyrosine Phosphatase , 2002, Molecular and Cellular Biology.

[37]  M. Tremblay,et al.  The T Cell Protein Tyrosine Phosphatase Is a Negative Regulator of Janus Family Kinases 1 and 3 , 2002, Current Biology.

[38]  W. Cavenee,et al.  The Protein Tyrosine Phosphatase TCPTP Suppresses the Tumorigenicity of Glioblastoma Cells Expressing a Mutant Epidermal Growth Factor Receptor* , 2001, The Journal of Biological Chemistry.

[39]  J. Crabtree,et al.  Bidirectional transcriptional activity of PGK‐neomycin and unexpected embryonic lethality in heterozygote chimeric knockout mice , 2001, Genesis.

[40]  R. Baron,et al.  Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. , 2000, The Journal of clinical investigation.

[41]  T. Braun,et al.  Myf-5 Revisited Loss of Early Myotome Formation Does Not Lead to a Rib Phenotype in Homozygous Myf-5 Mutant Mice , 2000, Cell.

[42]  B. Kemp,et al.  The Protein-tyrosine Phosphatase TCPTP Regulates Epidermal Growth Factor Receptor-mediated and Phosphatidylinositol 3-Kinase-dependent Signaling* , 1999, The Journal of Biological Chemistry.

[43]  M. Rudnicki,et al.  Strain-Dependent Myeloid Hyperplasia, Growth Deficiency, and Accelerated Cell Cycle in Mice Lacking the Rb-Related p107 Gene , 1998, Molecular and Cellular Biology.

[44]  N. Tonks,et al.  Epidermal Growth Factor Receptor and the Adaptor Protein p52Shc Are Specific Substrates of T-Cell Protein Tyrosine Phosphatase , 1998, Molecular and Cellular Biology.

[45]  John Wagner,et al.  Impaired Bone Marrow Microenvironment and Immune Function in T Cell Protein Tyrosine Phosphatase–deficient Mice , 1997, The Journal of experimental medicine.

[46]  M. Farrall,et al.  Mapping of a major genetic modifier of embryonic lethality in TGFβ1 knockout mice , 1997, Nature Genetics.

[47]  L. Tsui,et al.  Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor , 1996, Nature Genetics.

[48]  E. Wagner,et al.  Strain-dependent epithelial defects in mice lacking the EGF receptor. , 1995, Science.

[49]  K. Herrup,et al.  Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. , 1995, Science.

[50]  K. Mossman.  The Wellcome Trust Case Control Consortium, U.K. , 2008 .

[51]  N. Aoki,et al.  A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus. , 2002, Molecular endocrinology.

[52]  N. Tonks,et al.  Epidermal Growth Factor Receptor and the Adaptor Protein p 52 Shc Are Specific Substrates of T-Cell Protein Tyrosine Phosphatase , 1998 .